Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (1331-1340 of 3,827) with videos related to

Pageof 383
Sort By:
Cancer Cell|October 16, 2007
Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulationKoji Itahana, Hua Mao, Aiwen Jin, et al.
Cancer Cell|November 13, 2007
NOTCH and PI3K-AKT pathways intertwinedAlejandro Gutierrez, A Thomas Look
Cancer Cell|November 13, 2007
p53 enters the microRNA worldHeiko Hermeking
Cancer Cell|November 13, 2007
Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancerJindan Yu, Qi Cao, Rohit Mehra, et al.
Cancer Cell|November 13, 2007
Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumorsMona L Gauthier, Hal K Berman, Caroline Miller, et al.
Cancer Cell|June 15, 2007
Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTENIgor Vivanco, Nicolaos Palaskas, Chris Tran, et al.
Cancer Cell|August 19, 2007
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agentsJing Deng, Nicole Carlson, Kunihiko Takeyama, et al.
Cancer Cell|November 19, 2011
Platelets alter tumor cell attributes to propel metastasis: programming in transitLaurie J Gay, Brunhilde Felding-Habermann
Cancer Cell|November 19, 2011
Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasisMyriam Labelle, Shahinoor Begum, Richard O Hynes
Cancer Cell|November 19, 2011
A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cellsLars Anders, Nan Ke, Per Hydbring, et al.
Pageof 383

Showing results (1331-1340 of 3,827) with videos related to

Sort By:
Pageof 383
Cancer Cell|October 16, 2007
Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulationKoji Itahana, Hua Mao, Aiwen Jin, et al.
Cancer Cell|November 13, 2007
NOTCH and PI3K-AKT pathways intertwinedAlejandro Gutierrez, A Thomas Look
Cancer Cell|November 13, 2007
p53 enters the microRNA worldHeiko Hermeking
Cancer Cell|November 13, 2007
Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancerJindan Yu, Qi Cao, Rohit Mehra, et al.
Cancer Cell|November 13, 2007
Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumorsMona L Gauthier, Hal K Berman, Caroline Miller, et al.
Cancer Cell|June 15, 2007
Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTENIgor Vivanco, Nicolaos Palaskas, Chris Tran, et al.
Cancer Cell|August 19, 2007
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agentsJing Deng, Nicole Carlson, Kunihiko Takeyama, et al.
Cancer Cell|November 19, 2011
Platelets alter tumor cell attributes to propel metastasis: programming in transitLaurie J Gay, Brunhilde Felding-Habermann
Cancer Cell|November 19, 2011
Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasisMyriam Labelle, Shahinoor Begum, Richard O Hynes
Cancer Cell|November 19, 2011
A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cellsLars Anders, Nan Ke, Per Hydbring, et al.
Pageof 383